CW November 2004Issue Number 11 November 2004 ISSN 10593802 Quality-of-Life Study for Breast Cancer DrugsAnastrozole, an aromatase inhibitor that is used as adjuvant therapy for breast cancer patients, is found to work better than tamoxifen in warding off cancer recurrence and produces different side effects that might warrant consideration when choosing the best therapy.
Go to Previous Page Go to Next Page Source & Additional Reading D. Cella et al., Journal of Clinical Oncology, November 1, 2004. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW November 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |